C Elizabeth Caldon - JoVE Visualize

Showing results (21-30 of 48) with videos related to

Pageof 5

Sort By:

Journal of Clinical Microbiology|November 6, 2004

Carious dentine provides a habitat for a complex array of novel Prevotella-like bacteriaMangala A Nadkarni, C Elizabeth Caldon, Kim-Ly Chhour, et al.

Molecular and Cellular Biology|July 1, 2009

Estrogen regulation of cyclin E2 requires cyclin D1 but not c-MycC Elizabeth Caldon, C Marcelo Sergio, Judith Schütte, et al.

Cancers|June 24, 2022

<i>MCC</i> Gene Silencing Is a CpG Island Methylator Phenotype-Associated Factor That Predisposes Colon Cancer Cells to Irinotecan and OlaparibZeenat Jahan, Fahad A Benthani, Nicola Currey, et al.

Oncogene|October 19, 2004

Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1Alexander Swarbrick, Mia C Akerfeldt, Christine S L Lee, et al.

Journal of Clinical Pathology|December 16, 2014

Cell cycle marker expression in benign and malignant intraductal papillary lesions of the breastSeow Foong Loh, Caroline Cooper, Christina I Selinger, et al.

International Journal of Oncology|February 20, 2015

The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivoJohana M Susanto, Emily K Colvin, Mark Pinese, et al.

Journal of Cell Science|February 14, 2016

PP1 initiates the dephosphorylation of MASTL, triggering mitotic exit and bistability in human cellsSamuel Rogers, Dirk Fey, Rachael A McCloy, et al.

Nature Communications|December 1, 2024

SAM-DNMT3A, a strategy for induction of genome-wide DNA methylation, identifies DNA methylation as a vulnerability in ER-positive breast cancersMahnaz Hosseinpour, Xinqi Xi, Ling Liu, et al.

Nature Communications|January 26, 2019

Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancerQian Du, Saul A Bert, Nicola J Armstrong, et al.

Breast Cancer Research : BCR|August 14, 2020

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancerNeil Portman, Heloisa H Milioli, Sarah Alexandrou, et al.

Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:

Pageof 5

Journal of Clinical Microbiology|November 6, 2004

Carious dentine provides a habitat for a complex array of novel Prevotella-like bacteriaMangala A Nadkarni, C Elizabeth Caldon, Kim-Ly Chhour, et al.

Molecular and Cellular Biology|July 1, 2009

Estrogen regulation of cyclin E2 requires cyclin D1 but not c-MycC Elizabeth Caldon, C Marcelo Sergio, Judith Schütte, et al.

Cancers|June 24, 2022

<i>MCC</i> Gene Silencing Is a CpG Island Methylator Phenotype-Associated Factor That Predisposes Colon Cancer Cells to Irinotecan and OlaparibZeenat Jahan, Fahad A Benthani, Nicola Currey, et al.

Oncogene|October 19, 2004

Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1Alexander Swarbrick, Mia C Akerfeldt, Christine S L Lee, et al.

Journal of Clinical Pathology|December 16, 2014

Cell cycle marker expression in benign and malignant intraductal papillary lesions of the breastSeow Foong Loh, Caroline Cooper, Christina I Selinger, et al.

International Journal of Oncology|February 20, 2015

The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivoJohana M Susanto, Emily K Colvin, Mark Pinese, et al.

Journal of Cell Science|February 14, 2016

PP1 initiates the dephosphorylation of MASTL, triggering mitotic exit and bistability in human cellsSamuel Rogers, Dirk Fey, Rachael A McCloy, et al.

Nature Communications|December 1, 2024

SAM-DNMT3A, a strategy for induction of genome-wide DNA methylation, identifies DNA methylation as a vulnerability in ER-positive breast cancersMahnaz Hosseinpour, Xinqi Xi, Ling Liu, et al.

Nature Communications|January 26, 2019

Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancerQian Du, Saul A Bert, Nicola J Armstrong, et al.

Breast Cancer Research : BCR|August 14, 2020

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancerNeil Portman, Heloisa H Milioli, Sarah Alexandrou, et al.

Pageof 5